Sirtuins in cognitive ageing and Alzheimer's disease
- PMID: 22327552
- DOI: 10.1097/YCO.0b013e32835112c1
Sirtuins in cognitive ageing and Alzheimer's disease
Abstract
Purpose of review: Sirtuins are a family of enzymes highly conserved in evolution and involved in mechanisms known to promote healthy ageing and longevity. This review aims to discuss recent advances in understanding the role of sirtuins, in particular mammalian SIRT1, in promoting longevity and its potential molecular basis for neuroprotection against cognitive ageing and Alzheimer's disease pathology.
Recent findings: Accumulative increase in oxidative stress during ageing has been shown to decrease SIRT1 activity in catabolic tissue, possibly by direct inactivation by reactive oxygen. SIRT1 overexpression prevents oxidative stress-induced apoptosis and increases resistance to oxidative stress through regulation of the FOXO family of forkhead transcription factors. In addition, resveratrol strongly stimulates SIRT1 deacetylase activity in a dose-dependent manner by increasing its binding affinity to both the acetylated substrate and NAD(+). Recently, SIRT1 has been shown to affect amyloid production through its influence over the ADAM10 gene. Upregulation of SIRT1 can also induce the Notch pathway and inhibit mTOR signalling.
Summary: Recent studies have revealed some of the mechanisms and pathways that are associated with the neuroprotective effects of SIRT1.
Similar articles
-
Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease.Drug News Perspect. 2007 May;20(4):233-9. doi: 10.1358/dnp.2007.20.4.1101162. Drug News Perspect. 2007. PMID: 17637936 Review.
-
Sirt1 protects the heart from aging and stress.Biol Chem. 2008 Mar;389(3):221-31. doi: 10.1515/BC.2008.032. Biol Chem. 2008. PMID: 18208353 Review.
-
Neuronal protection by sirtuins in Alzheimer's disease.J Neurochem. 2006 Jan;96(2):305-13. doi: 10.1111/j.1471-4159.2005.03492.x. Epub 2005 Oct 7. J Neurochem. 2006. PMID: 16219030 Review.
-
[Neuroprotective role of silent information regulator 1 in Alzheimer's disease].Sheng Li Xue Bao. 2011 Aug 25;63(4):396-400. Sheng Li Xue Bao. 2011. PMID: 21861060 Review. Chinese.
-
Resveratrol--a boon for treating Alzheimer's disease?Brain Res Rev. 2006 Sep;52(2):316-26. doi: 10.1016/j.brainresrev.2006.04.004. Brain Res Rev. 2006. PMID: 16766037 Review.
Cited by
-
Insights into Lysine Deacetylation of Natively Folded Substrate Proteins by Sirtuins.J Biol Chem. 2016 Jul 8;291(28):14677-94. doi: 10.1074/jbc.M116.726307. Epub 2016 May 18. J Biol Chem. 2016. PMID: 27226597 Free PMC article.
-
High Levels of SIRT1 Expression as a Protective Mechanism Against Disease-Related Conditions.Front Endocrinol (Lausanne). 2018 Oct 15;9:614. doi: 10.3389/fendo.2018.00614. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30374331 Free PMC article. Review.
-
The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?Dialogues Clin Neurosci. 2014 Sep;16(3):373-93. doi: 10.31887/DCNS.2014.16.3/mmillan. Dialogues Clin Neurosci. 2014. PMID: 25364287 Free PMC article. Review.
-
Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview.Molecules. 2016 Apr 21;21(4):518. doi: 10.3390/molecules21040518. Molecules. 2016. PMID: 27110749 Free PMC article. Review.
-
When is Sirt1 activity bad for dying neurons?Front Cell Neurosci. 2013 Oct 24;7:186. doi: 10.3389/fncel.2013.00186. eCollection 2013. Front Cell Neurosci. 2013. PMID: 24167473 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous